Kim Tae-Won, Song In-Uk, Chung Sung-Woo
Department of Neurology,the College of Medicine,The Catholic University of Korea,Seoul,South Korea.
Can J Neurol Sci. 2017 Jul;44(4):404-409. doi: 10.1017/cjn.2016.299. Epub 2016 Sep 28.
Although D-dimer levels are significantly associated with cardioembolic infarction, the significance of D-dimer levels in relation to the severity and functional outcomes of other stroke subtypes, such as lacunar and large artery atherosclerosis infarction, remains unclear. The purpose of this study was to evaluate whether elevated initial D-dimer levels are significantly and cross-sectionally associated with poor functional outcomes at each time point during a 9-month follow-up period. We also investigated the significance of D-dimer levels in longitudinal temporal changes of functional outcomes in these patients.
We recruited 146 patients with lacunar infarction and 161 patients with large artery atherosclerosis infarction who were consecutively admitted to our hospital after acute stroke. Serum D-dimer levels were evaluated initially and the modified Rankin scale were measured initially and at 1-, 3-, 6-, and 9-month follow-up visits.
Patients with higher D-dimer levels had significantly worse initial functional outcomes, and these worse outcomes were maintained throughout the 9-month follow-up period compared with the low D-dimer group. However, regardless of stroke subtype, D-dimer levels did not influence long-term changes in functional outcomes over the 9-month follow-up period.
This study suggests that elevated D-dimer levels can be used as a surrogate marker for poor functional outcomes only during the acute stage. Further evaluation of serum D-dimer levels could provide a helpful predictive marker for stroke prognosis.
尽管D-二聚体水平与心源性栓塞性梗死显著相关,但D-二聚体水平与其他卒中亚型(如腔隙性梗死和大动脉粥样硬化性梗死)的严重程度及功能结局之间的关系仍不明确。本研究的目的是评估初始D-二聚体水平升高是否与9个月随访期内各时间点的不良功能结局存在显著的横断面关联。我们还研究了D-二聚体水平在这些患者功能结局纵向时间变化中的意义。
我们招募了146例腔隙性梗死患者和161例大动脉粥样硬化性梗死患者,这些患者在急性卒中后连续入住我院。最初评估血清D-二聚体水平,并在初始时以及1、3、6和9个月的随访时测量改良Rankin量表。
D-二聚体水平较高的患者初始功能结局明显较差,与低D-二聚体组相比,这些较差的结局在整个9个月的随访期内持续存在。然而,无论卒中亚型如何,D-二聚体水平在9个月的随访期内均未影响功能结局的长期变化。
本研究表明,D-二聚体水平升高仅在急性期可作为不良功能结局的替代标志物。进一步评估血清D-二聚体水平可为卒中预后提供有用的预测标志物。